Summary Background National Comprehensive Cancer Network guidelines consider 18 F-
fluciclovine PET-CT for prostate cancer biochemical recurrence localisation after radical …

18F-labeled prostate-specific membrane antigen (PSMA) PET tracers are increasingly used
in preference to 68Ga-PSMA-11 for restaging biochemical recurrence (BCR) of prostate …

Purpose The purpose of our study was to assess 18 F–DCFBC PET/CT, a PSMA targeted
PET agent, for lesion detection and clinical management of biochemical relapse in prostate …

A significant proportion of men with rising prostate-specific antigen (PSA) levels after radical
prostatectomy (RP) fail prostate fossa (PF) salvage radiation treatment (SRT). This study was …

This was a head-to-head comparison between 68 Ga-labeled prostate-specific membrane
antigen (PSMA)-11 and 18 F-fluciclovine PET/CT in a series of 10 patients with prostate …

Purpose One of the major challenges for all imaging modalities is accurate detection of
prostate cancer (PCa) recurrence. Beyond the established 68 Ga-PSMA, a novel promising …

Background National guidelines endorse fluorine 18 (18F) fluciclovine PET/CT for the
detection of prostate cancer (PCa) in men with biochemically recurrent PCa. The …

68Ga-labeled prostate-specific membrane antigen (PSMA) PET/CT is increasingly used in
men with biochemical recurrence (BCR) after radical prostatectomy (RP), but its longer-term …

Purpose The aim of the present study was to identify prostate-specific antigen (PSA)
threshold levels, as well as PSA velocity, progression rate and doubling time in relation to …

The aim of the study was to assess which factors may influence 11C-choline PET/CT
detection rate in a population of recurrent prostate cancer (PCa) patients listed for salvage …